Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fridkin

Showing results (201-210 of 515) with videos related to

Pageof 52
Sort By:
Journal of Physics. Condensed Matter : an Institute of Physics Journal|August 12, 2011
Nanoscale domain patterns in ultrathin polymer ferroelectric filmsP Sharma, T Reece, D Wu, et al.
Peptides|January 1, 1991
Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the ratJ M Hill, I Gozes, J L Hill, et al.
Molecular Cell|May 20, 2014
Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cellsLior Nissim, Samuel D Perli, Alexandra Fridkin, et al.
Journal of Neuroimmunology|June 17, 1998
Single amino acid analogs of a myasthenogenic peptide modulate specific T cell responses and prevent the induction of experimental autoimmune myasthenia gravisY Katz-Levy, M Dayan, I Wirguin, et al.
Brain Research|April 28, 2000
Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's diseaseD Offen, Y Sherki, E Melamed, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1999
Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptidesM Blank, Y Shoenfeld, S Cabilly, et al.
American Journal of Infection Control|December 18, 2001
Characteristics of hospitals and infection control professionals participating in the National Nosocomial Infections Surveillance System 1999C Richards, T G Emori, J Edwards, et al.
Advances in Experimental Medicine and Biology|January 1, 1982
Mechanisms controlling differentiation and function of antigen-presenting macrophagesM Feldman, E Tzehoval, Y Ron, et al.
Bioconjugate Chemistry|July 5, 2012
Newly designed modifier prolongs the action of short-lived peptides and proteins by allowing their binding to serum albuminYoram Shechter, Keren Sasson, Vered Lev-Goldman, et al.
Toxicology and Applied Pharmacology|October 27, 2019
Converting bleomycin into a prodrug that undergoes spontaneous reactivation under physiological conditionsItzik Cooper, Dana Atrakchi, Michael D Walker, et al.
Pageof 52

Showing results (201-210 of 515) with videos related to

Sort By:
Pageof 52
Journal of Physics. Condensed Matter : an Institute of Physics Journal|August 12, 2011
Nanoscale domain patterns in ultrathin polymer ferroelectric filmsP Sharma, T Reece, D Wu, et al.
Peptides|January 1, 1991
Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the ratJ M Hill, I Gozes, J L Hill, et al.
Molecular Cell|May 20, 2014
Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cellsLior Nissim, Samuel D Perli, Alexandra Fridkin, et al.
Journal of Neuroimmunology|June 17, 1998
Single amino acid analogs of a myasthenogenic peptide modulate specific T cell responses and prevent the induction of experimental autoimmune myasthenia gravisY Katz-Levy, M Dayan, I Wirguin, et al.
Brain Research|April 28, 2000
Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's diseaseD Offen, Y Sherki, E Melamed, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1999
Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptidesM Blank, Y Shoenfeld, S Cabilly, et al.
American Journal of Infection Control|December 18, 2001
Characteristics of hospitals and infection control professionals participating in the National Nosocomial Infections Surveillance System 1999C Richards, T G Emori, J Edwards, et al.
Advances in Experimental Medicine and Biology|January 1, 1982
Mechanisms controlling differentiation and function of antigen-presenting macrophagesM Feldman, E Tzehoval, Y Ron, et al.
Bioconjugate Chemistry|July 5, 2012
Newly designed modifier prolongs the action of short-lived peptides and proteins by allowing their binding to serum albuminYoram Shechter, Keren Sasson, Vered Lev-Goldman, et al.
Toxicology and Applied Pharmacology|October 27, 2019
Converting bleomycin into a prodrug that undergoes spontaneous reactivation under physiological conditionsItzik Cooper, Dana Atrakchi, Michael D Walker, et al.
Pageof 52